Skip to main content

A Phase III, Randomised, Double-blind, Placebo-controlled,Multicentre, Parallel-group Study with Extension Phase to Evaluate the Efficacy andSafety of Dysport® for the Prevention of Episodic Migraine in Adult Participants.

Open
  • Protocol code: CLIN-52120-464
  • EudraCT code: No aplica
  • Research group: Headache and Neurological Pain
  • Service: Neurology
  • Principal investigator:  Pozo Rosich, Patricia
  • Pathology: Malalties del sistema nerviós
  • Phase: Fase III